TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
Tarsus Pharmaceuticals (TARS) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $98.00 price target on the stock.
Tarsus Pharmaceuticals (TARS) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Tarsus Pharmaceuticals (TARS) was downgraded by Wall Street Zen from
Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses [Seeking Alpha]
Form 4 Tarsus Pharmaceuticals, For: Apr 24 Filed by: PYOTT DAVID E I
Form ARS Tarsus Pharmaceuticals, For: Dec 31
Form DEFA14A Tarsus Pharmaceuticals,
Form DEF 14A Tarsus Pharmaceuticals, For: Jun 25
Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: VANGUARD GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.